Harbour BioMed

Showing 2 posts of 2 posts found.


Harbour BioMed’s Batoclimab granted Breakthrough Therapy designation in China

January 28, 2021
Harbour BioMed

Harbour BioMed (HBM) has announced that China’s Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab, a …


AbbVie buys COVID-19 antibody licence from Harbour BioMed

December 16, 2020
Research and Development AbbVie, COVID-19, Harbour BioMed, antibody

Harbour BioMed (HBM) and Utrecht University (UU) have announced that their fully human, SARS-CoV-2 neutralising antibody 47D11 and programme, has …

Latest content